Saikosaponin a inhibits the proliferation and activation of T cells through cell cycle arrest and induction of apoptosis

Int Immunopharmacol. 2009 Jul;9(7-8):978-83. doi: 10.1016/j.intimp.2009.04.006. Epub 2009 Apr 16.

Abstract

In the present study, we aimed at examining the immunosuppressive activity of saikosaponin a, a triterpene saponin derived from Bupleurum falcatum L. (Umbelliferae), and the underlying mechanisms. Saikosaponin a significantly inhibited the proliferation and activation of T cells activated by concanavalin A (Con A) in a concentration-dependent manner. Additionally, it potently suppressed Con A-stimulated IL-2, IFN-gamma and TNF-alpha production in mouse T cells. Saikosaponin a also caused G0/G1 arrest of activated T cells through down-regulating the protein levels of CDK6 and Cyclin D3 and up-regulating the protein level of p27(kip). Furthermore, the compound dose-dependently induced apoptosis of Con A-activated T cells rather than those non-activated, as determined by Annexin V/PI staining. Besides, it induced a remarkable collapse of mitochondrial membrane potential and caused significant release of cytochrome c from mitochondria to cytosol. In summary, these results suggest that the G0/G1 arrest as well as the induction of apoptosis via mitochondrial pathway are involved in the immunosuppressive activity of saikosaponin a against activated T cells. This may herald a novel approach for further studies of saikosaponin a as a candidate for the treatment of inflammatory and autoimmune diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Apoptosis / immunology
  • Autoimmune Diseases / drug therapy
  • Bupleurum*
  • Cell Cycle / drug effects
  • Cell Cycle / immunology
  • Cell Proliferation / drug effects
  • Cyclin D3
  • Cyclin-Dependent Kinase 6 / genetics
  • Cyclin-Dependent Kinase 6 / immunology
  • Cyclin-Dependent Kinase 6 / metabolism
  • Cyclin-Dependent Kinase Inhibitor p27 / genetics
  • Cyclin-Dependent Kinase Inhibitor p27 / immunology
  • Cyclin-Dependent Kinase Inhibitor p27 / metabolism*
  • Cyclins / genetics
  • Cyclins / immunology
  • Cyclins / metabolism*
  • Cytochromes c / metabolism
  • Dose-Response Relationship, Drug
  • Down-Regulation
  • Female
  • Immunosuppression Therapy
  • Interferon-gamma / genetics
  • Interferon-gamma / metabolism
  • Interleukin-2 / genetics
  • Interleukin-2 / metabolism
  • Lymphocyte Activation / drug effects
  • Lymphocyte Activation / immunology
  • Membrane Potential, Mitochondrial / drug effects
  • Membrane Potential, Mitochondrial / immunology
  • Mice
  • Mice, Inbred BALB C
  • Oleanolic Acid / analogs & derivatives*
  • Oleanolic Acid / pharmacology
  • Saponins / pharmacology*
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism*
  • T-Lymphocytes / pathology
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / metabolism
  • Up-Regulation

Substances

  • Ccnd3 protein, mouse
  • Cdkn1b protein, mouse
  • Cyclin D3
  • Cyclins
  • Interleukin-2
  • Saponins
  • Tumor Necrosis Factor-alpha
  • Cyclin-Dependent Kinase Inhibitor p27
  • Oleanolic Acid
  • Interferon-gamma
  • Cytochromes c
  • Cyclin-Dependent Kinase 6
  • saikosaponin D